Beta Drugs Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE351Y01019
  • NSEID: BETA
  • BSEID:
INR
1,554.00
4.6 (0.3%)
BSENSE

Dec 19

BSE+NSE Vol: 5322

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
10.09
9.61
9.61
9.61
9.61
9.61
Share Warrants & Outstandings
Total Reserve
187.00
147.50
113.27
82.73
59.00
47.50
Shareholder's Funds
197.10
157.12
122.88
92.34
68.61
57.11
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
126.99
6.04
6.97
11.83
11.13
10.28
Secured Loans
9.99
6.04
6.97
11.83
11.13
10.28
Unsecured Loans
117.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-1.83
-1.41
-1.20
-0.68
-0.65
-0.17
Other Long Term Liabilities
9.41
6.27
5.55
4.71
4.46
3.1
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
134.58
10.90
11.32
15.86
14.95
13.21
Current Liabilities
Trade Payables
71.25
59.27
40.24
31.95
20.49
14.49
Other Current Liabilities
25.77
20.44
13.71
12.26
9.26
12.55
Short Term Borrowings
5.71
4.96
9.07
4.75
3.54
9.65
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
102.73
84.67
63.02
48.97
33.30
36.69
Total Liabilities
434.41
252.69
197.22
157.17
116.86
107.01
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
146.30
109.49
99.37
82.17
61.14
58.29
Less: Accumulated Depreciation
57.37
44.90
36.61
27.22
21.17
14.46
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
88.93
64.59
62.76
54.95
39.97
43.82
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
2.81
0.07
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.78
0.78
0.78
0.35
Long Term Loans & Advances
14.14
10.17
5.95
4.43
1.85
1.57
Other Non Current Assets
3.00
0.06
2.80
2.80
6.15
7.90
Total Non-Current Assets
103.33
74.82
69.54
60.21
48.82
50.97
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
59.77
49.81
30.62
22.48
16.04
12.35
Sundry Debtors
102.58
79.24
62.72
45.18
33.88
31.93
Cash and Bank
147.02
28.63
19.16
17.32
10.42
5.39
Other Current Assets
12.39
13.03
9.09
7.49
5.27
4.48
Short Term Loans and Advances
9.31
7.15
6.09
4.48
2.42
1.90
Total Current Assets
331.08
177.87
127.68
96.96
68.04
56.04
Net Current Assets (Including Current Investments)
228.35
93.20
64.67
47.99
34.74
19.35
Total Current Assets Excluding Current Investments
331.08
177.87
127.68
96.96
68.04
56.04
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
434.41
252.69
197.22
157.17
116.86
107.01
Contingent Liabilities
1.73
1.55
1.55
0.00
0.00
0.73
Total Debt
132.71
11.00
16.04
16.58
14.67
19.95
Book Value per share (adjusted)
195.25
155.647619047619
127.82
96.05
71.37
59.41
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 1,106.45% vs -31.42% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 50.08% vs 12.97% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 37.68% vs 2.92% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 86.14% vs 39.31% in Mar 2024

Compare Balance Sheet Results of Beta Drugs Ltd
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
10.09
0
10.09
0.00%
Share Warrants & Outstandings
Total Reserve
187.00
0
187.00
0.00%
Shareholder's Funds
197.10
0
197.10
0.00%
Minority Interest
0.00
0
0.00
0.00%
Long-Term Borrowings
126.99
0
126.99
0.00%
Secured Loans
9.99
0
9.99
0.00%
Unsecured Loans
117.00
0
117.00
0.00%
Deferred Tax Assets / Liabilities
-1.83
0
-1.83
0.00%
Other Long Term Liabilities
9.41
0
9.41
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.00
0
0.00
0.00%
Total Non-Current Liabilities
134.58
0
134.58
0.00%
Current Liabilities
Trade Payables
71.25
0
71.25
0.00%
Other Current Liabilities
25.77
0
25.77
0.00%
Short Term Borrowings
5.71
0
5.71
0.00%
Short Term Provisions
0.00
0
0.00
0.00%
Total Current Liabilities
102.73
0
102.73
0.00%
Total Liabilities
434.41
0
434.41
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
146.30
0
146.30
0.00%
Less: Accumulated Depreciation
57.37
0
57.37
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
88.93
0
88.93
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
0.00
0
0.00
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.00
0
0.00
0.00%
Long Term Loans & Advances
14.14
0
14.14
0.00%
Other Non Current Assets
3.00
0
3.00
0.00%
Total Non-Current Assets
103.33
0
103.33
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
59.77
0
59.77
0.00%
Sundry Debtors
102.58
0
102.58
0.00%
Cash and Bank
147.02
0
147.02
0.00%
Other Current Assets
12.39
0
12.39
0.00%
Short Term Loans and Advances
9.31
0
9.31
0.00%
Total Current Assets
331.08
0
331.08
0.00%
Net Current Assets (Including Current Investments)
228.35
0
228.35
0.00%
Total Current Assets Excluding Current Investments
331.08
0
331.08
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
434.41
0
434.41
0.00%
Contingent Liabilities
1.73
0
1.73
0.00%
Total Debt
132.71
0
132.71
0.00%
Book Value per share (adjusted)
195.25
0
195.25
0.00%
Annual - Borrowings
Borrowings 132.71 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 1,106.45% vs -31.42% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 9.41 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 50.08% vs 12.97% in Mar 2024

Annual - Fixed Assets
Fixed Assets 88.93 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 37.68% vs 2.92% in Mar 2024

Annual - Investments
Investments 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024

Annual - Current Assets
Current Assets 331.08 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 86.14% vs 39.31% in Mar 2024